WLK WESTLAKE CORP
Industrial Organic Chemicals · NYSE · SEC CIK 1262823 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.4%
TTM net income YoY53.3%
TTM EPS YoY53.2%
Revenue 3-yr CAGR-4.2%
Net income 3-yr CAGR—
Margins
Gross margin10.8%
Operating margin-3.8%
Net margin-3.9%
FCF margin0.1%
EBITDA margin6.3%
Returns
ROE-4.9%
ROA-2.3%
ROIC (approx.)-2.9%
Asset turnover0.59x
Leverage & solvency
Liabilities / assets52.5%
Debt / equity0.58x
Current ratio2.38x
Interest coverage-2.04x
Cash quality & payout
Operating cash flow / net income-1.89x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue7.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $11.17B | $12.14B |
| Cost of revenue | $10.36B | $10.19B |
| Gross profit | $813.00M | $1.96B |
| SG&A expense | $900.00M | $874.00M |
| Operating income | -$1.58B | $875.00M |
| Interest expense | $171.00M | $159.00M |
| Pretax income | -$1.60B | $938.00M |
| Income tax | -$126.00M | $291.00M |
| Net income | -$1.51B | $602.00M |
| EBITDA | -$400.00M | $1.99B |
| EPS (basic) | -11.70 | 4.66 |
| EPS (diluted) | -11.70 | 4.64 |
| Dividends declared per share | 2.11 | 2.05 |
| Weighted avg. shares (diluted) | 128.26M | 129.21M |
| Balance sheet | ||
| Cash & equivalents | $2.72B | $2.94B |
| Short-term investments | $204.00M | $0 |
| Receivables | $1.23B | $1.31B |
| Inventory | $1.65B | $1.70B |
| Current assets | $6.22B | $6.21B |
| PP&E, net | $8.61B | $8.63B |
| Goodwill | $1.31B | $2.03B |
| Intangibles | $743.00M | $820.00M |
| Total assets | $19.96B | $20.75B |
| Current liabilities | $2.77B | $2.22B |
| Short-term debt | $497.00M | $6.00M |
| Long-term debt | $5.09B | $4.56B |
| Total debt | $5.58B | $4.56B |
| Total liabilities | $10.67B | $9.71B |
| Shareholders' equity | $8.79B | $10.53B |
| Net debt | $2.86B | $1.63B |
| Cash flow statement | ||
| Operating cash flow | $465.00M | $1.31B |
| Capital expenditure | $995.00M | $1.01B |
| Free cash flow | -$530.00M | $306.00M |
| Investing cash flow | -$1.22B | -$1.00B |
| Financing cash flow | $530.00M | -$650.00M |
| Depreciation & amortization | $1.18B | $1.11B |
| Stock-based compensation | $41.00M | $41.00M |
| Dividends paid | $272.00M | $264.00M |
| Share buybacks | $63.00M | $60.00M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.